Mercury Laboratories Intrinsic Value
Mercury Laboratories (MERCURYLAB) median intrinsic value is ₹691.01 from 9 valuation models (range ₹229–₹1490), vs current price ₹745.00 — -7.2% downside (Trading Near Calculated Value), margin of safety -7.8%. For current market price and key ratios, visit MERCURYLAB stock live price.
MERCURYLAB Valuation Methods Summary — DCF, Graham Number & P/E
Mercury Laboratories intrinsic value across 9 models vs current price ₹745.00 — upside/downside and value range per method. Browse MERCURYLAB cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹864.60 | ₹691.68 - ₹1037.52 | +16.1% | EPS: ₹39.30, Sector P/E: 22x |
| Book Value Method | asset | ₹1080.00 | ₹972.00 - ₹1188.00 | +45.0% | Book Value/Share: ₹540.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1490.00 | ₹1341.00 - ₹1639.00 | +100.0% | Revenue/Share: ₹780.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1000.00 | ₹900.00 - ₹1100.00 | +34.2% | EBITDA: ₹10.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹371.35 | ₹297.08 - ₹445.62 | -50.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹228.60 | ₹205.74 - ₹251.46 | -69.3% | EPS Growth: 7.3%, Fair P/E: 5.8x |
| Growth Adjusted P/E | growth | ₹610.81 | ₹549.73 - ₹671.89 | -18.0% | Revenue Growth: 7.2%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹500.00 | ₹450.00 - ₹550.00 | -32.9% | ROE: 9.3%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹691.01 | ₹621.91 - ₹760.11 | -7.2% | EPS: ₹39.30, BVPS: ₹540.00 |
MERCURYLAB Intrinsic Value vs Market Price — All Valuation Models
Mercury Laboratories fair value range ₹229–₹1490 vs current market price ₹745.00 across 9 valuation models. Compare with MERCURYLAB fair price to assess whether the stock is under or overvalued.
MERCURYLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Mercury Laboratories median intrinsic value ₹691.01, current price ₹745.00 — Trading Near Calculated Value by 7.2%, margin of safety -7.8%.
What is the intrinsic value of MERCURYLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Mercury Laboratories (MERCURYLAB) is ₹691.01 (median value). With the current market price of ₹745.00, this represents a -7.2% variance from our estimated fair value.
The valuation range spans from ₹228.60 to ₹1490.00, indicating ₹228.60 - ₹1490.00.
Is MERCURYLAB undervalued or overvalued?
Based on our multi-method analysis, Mercury Laboratories (MERCURYLAB) appears to be trading near calculated value by approximately 7.2%.
MERCURYLAB Financial Health — Key Ratios vs Industry Benchmarks
Mercury Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.67 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.05x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MERCURYLAB Cash Flow Quality — Operating & Free Cash Flow
Mercury Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹4 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹8 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹8 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |